Therefore, this study aimed at investigating the role of let-7a and underlying molecular mechanism by targeting TNFAIP3 in pediatric HSP patients and provided new therapeutic targets for the treatment of HSP children. The gene discussed is TNFAIP3; the disease is hereditary spastic paraplegia.